Nash Family Department of Neuroscience, and Friedman Brain Institute.
Department of Laboratory Medicine, University of Crete Faculty of Medicine, 71003 Heraklion, Greece, and.
J Neurosci. 2019 Oct 16;39(42):8291-8304. doi: 10.1523/JNEUROSCI.3154-18.2019. Epub 2019 Jul 15.
Regulator of G-protein signaling 4 (RGS4) is a potent modulator of G-protein-coupled receptor signal transduction that is expressed throughout the pain matrix. Here, we use genetic mouse models to demonstrate a role of RGS4 in the maintenance of chronic pain states in male and female mice. Using paradigms of peripheral inflammation and nerve injury, we show that the prevention of RGS4 action leads to recovery from mechanical and cold allodynia and increases the motivation for wheel running. Similarly, RGS4KO eliminates the duration of nocifensive behavior in the second phase of the formalin assay. Using the Complete Freud's Adjuvant (CFA) model of hindpaw inflammation we also demonstrate that downregulation of RGS4 in the adult ventral posterolateral thalamic nuclei promotes recovery from mechanical and cold allodynia. RNA sequencing analysis of thalamus (THL) from RGS4WT and RGS4KO mice points to many signal transduction modulators and transcription factors that are uniquely regulated in CFA-treated RGS4WT cohorts. Ingenuity pathway analysis suggests that several components of glutamatergic signaling are differentially affected by CFA treatment between RGS4WT and RGS4KO groups. Notably, Western blot analysis shows increased expression of metabotropic glutamate receptor 2 in THL synaptosomes of RGS4KO mice at time points at which they recover from mechanical allodynia. Overall, our study provides information on a novel intracellular pathway that contributes to the maintenance of chronic pain states and points to RGS4 as a potential therapeutic target. There is an imminent need for safe and efficient chronic pain medications. Regulator of G-protein signaling 4 (RGS4) is a multifunctional signal transduction protein, widely expressed in the pain matrix. Here, we demonstrate that RGS4 plays a prominent role in the maintenance of chronic pain symptoms in male and female mice. Using genetically modified mice, we show a dynamic role of RGS4 in recovery from symptoms of sensory hypersensitivity deriving from hindpaw inflammation or hindlimb nerve injury. We also demonstrate an important role of RGS4 actions in gene expression patterns induced by chronic pain states in the mouse thalamus. Our findings provide novel insight into mechanisms associated with the maintenance of chronic pain states and demonstrate that interventions in RGS4 activity promote recovery from sensory hypersensitivity symptoms.
G 蛋白信号调节因子 4(RGS4)是一种强效的 G 蛋白偶联受体信号转导调节剂,广泛表达于痛觉相关区域。在此,我们利用基因敲除小鼠模型证明了 RGS4 在维持雄性和雌性小鼠慢性痛觉状态中的作用。通过外周炎症和神经损伤模型,我们发现抑制 RGS4 活性可使机械性和冷感觉过敏恢复,同时增加动物转轮运动的活跃度。同样地,RGS4 基因敲除消除了福尔马林试验第二阶段的伤害性行为持续时间。使用完全弗氏佐剂(CFA)后爪炎症模型,我们还证明成年小鼠腹后外侧丘脑核中 RGS4 的下调可促进机械性和冷感觉过敏的恢复。对 RGS4WT 和 RGS4KO 小鼠丘脑(THL)的 RNA 测序分析表明,许多信号转导调节剂和转录因子在 CFA 处理的 RGS4WT 队列中受到独特调控。Ingenuity 通路分析表明,CFA 处理的 RGS4WT 和 RGS4KO 组之间,谷氨酸能信号的几个组成部分受到不同影响。值得注意的是,Western blot 分析显示,在 RGS4KO 小鼠从机械性痛觉过敏中恢复的时间点,THL 突触体中代谢型谷氨酸受体 2 的表达增加。总之,我们的研究提供了有关一种新的细胞内通路的信息,该通路有助于维持慢性痛觉状态,并表明 RGS4 是一种有潜力的治疗靶点。目前迫切需要安全有效的慢性疼痛治疗药物。RGS4 是一种多功能信号转导蛋白,广泛表达于痛觉相关区域。在此,我们证明 RGS4 在维持雄性和雌性小鼠慢性痛觉症状中发挥重要作用。利用基因修饰小鼠,我们发现 RGS4 在从后爪炎症或后肢神经损伤引起的感觉过敏症状恢复中具有动态作用。我们还证明了 RGS4 活性在慢性痛觉状态诱导的小鼠丘脑基因表达模式中的重要作用。我们的研究结果为与慢性痛觉状态维持相关的机制提供了新的见解,并表明干预 RGS4 活性可促进感觉过敏症状的恢复。